CD4 and arthritic joint disease: Transferring CD4+CD25+ T cells from B29-immunized donors from both, differently pre-treated groups, resulted in a similar suppression of clinical symptoms of arthritis as compared with the transfer of CD4+CD25- control cells (Fig 4).